FDA
-
-
-
-
-
-
-
Apricus Biosciences Provides Corporate Update and First Quarter 2018 Financial Results
-
-
-
-
-
-
-
Apricus Biosciences Announces Scheduling of Vitaros(TM) End-of-Review Meeting with FDA
-
-
-
-
-
-
-
Apricus Biosciences Announces Corporate Update, Fourth Quarter and Full Year 2017 Financial Results Conference Call
-
-
-
-
-
-
-
Apricus Biosciences (APRI) Announces $3.7M Private Placement of Common Stock, Warrants
-
-
-
-
-
-
-
Apricus Biosciences (APRI) Tops Q2 EPS by 3c
-
-
-
-
-
-
-
Pre-Open Movers 03/31: (SORL) (BBRY) (BDSI) Higher; (DRIO) (BLRX) (CTSO) Lower (more...)
-
-
-
-
-
-
-
Innovus Pharma Expands its Executive Management Team with the Addition of Randy Berholtz as its Executive Vice President, Corporate Development and General Counsel
-
323,806 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

